Pharma and Biotech Patent Litigation Conference

C5
January 28-29, 2014

John Murnane spoke on “Patent Eligible Subject Matter after Association for Molecular Pathology v. Myriad Genetics” at the Pharma and Biotech Patent Litigation conference in Amsterdam on January 28-29. Gabrielle Markeson helped prepare the presentation.